Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Out-of-sequence (OOS) kidney allocation has become increasingly prevalent since 2021. We examined the relationship between organ procurement organization (OPO) OOS allocation frequency and kidney nonuse rates. Among 57 OPOs between March 2021 and December 2023, we analyzed trends in OOS utilization and its association with kidney nonuse rates. There was significant variability in OOS use across OPOs, with some allocating over 20% of kidneys out-of-sequence over the entire period. An absolute increase of 1 SD (12.8%) of OOS allocation was modestly associated with a reduction in kidney nonuse rates (incidence risk ratio = 0.98; P = .04). Donor characteristics, particularly older age, donation after circulatory death, and high kidney donor profile index, were the strongest predictors of nonuse. While OOS allocation may mitigate logistical challenges, other strategies may be more effective at reducing the nonuse rate.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310372 | PMC |
| http://dx.doi.org/10.1016/j.ajt.2025.02.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of spironolactone on cardiovascular and renal outcomes in patients with chronic kidney disease.
Clin Kidney J
September 2025
Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Background: Steroidal mineralocorticoid receptor antagonists (MRAs), including spironolactone, effectively treat resistant hypertension, reduce proteinuria and lower mortality in heart failure with reduced ejection fraction. However, their long-term effects in chronic kidney disease (CKD) remain unclear. This study investigated spironolactone's impact on end-stage renal disease (ESRD), major adverse cardiovascular events (MACE), hyperkalemia and mortality in CKD patients.
View Article and Find Full Text PDFSafety and effectiveness of contraception among women with chronic kidney disease: a systematic review.
Contraception
September 2025
Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA, United States, 30341.
Objectives: To systematically review evidence on the safety and effectiveness of contraceptive use among women with chronic kidney disease (CKD).
Study Design: We searched for articles in multiple databases from database inception through December 12, 2022, that assessed safety and effectiveness of contraceptive use among women with CKD; all study designs were included. We extracted data from included articles; for studies that were not case series or case reports, we assessed risk of bias and determined certainty of evidence for each outcome.
Characteristics and Related Factors of Chinese Herbal Medicine Use in Middle-Aged and Older Patients with Cardiovascular Disease in China: A Cross-Sectional Study.
Patient Prefer Adherence
August 2025
Department of Rehabilitation Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Background: Cardiovascular disease (CVD) poses a significant health burden in middle-aged and older Chinese populations, with Chinese herbal medicine (CHM) often used as a complementary therapy. This study aimed to analyze the characteristics of CHM use and its influencing factors in middle-aged and older Chinese patients with CVD.
Methods: This was a cross-sectional study based on data from the 2018 China Health and Aging Longitudinal Study (CHARLS).
Improving deceased donor kidney utilization: predicting risk of nonuse with interpretable models.
Front Artif Intell
August 2025
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States.
Background: Many deceased donor kidneys go unused despite growing demand for transplantation. Early identification of organs at high risk of nonuse can facilitate effective allocation interventions, ensuring these organs are offered to patients who could potentially benefit from them. While several machine learning models have been developed to predict nonuse risk, the complexity of these models compromises their practical implementation.
View Article and Find Full Text PDFElectronic cigarette use and risk of chronic kidney disease: a dose-response analysis with propensity score matching in a nationally representative cohort.
BMC Public Health
August 2025
Department of Urology, Kaifeng155 Hospital, RongTong Medical Healthcare Group Co.Ltd, Kaifeng, 475000, China.
Background: The long-term renal effects of electronic cigarette (e-cigarette) use remain poorly understood, despite its global rise as a nicotine delivery system. This study investigates the association between e-cigarette use and chronic kidney disease (CKD), with emphasis on dose-response relationships, subgroup heterogeneity, and adjustment for cigarette smoking.
Methods: We analyzed data from 872 adults in NHANES (2017-2020).